Jared Gollob, Chief Medical Officer: Kymera Therapeutics KYMR Sell · Filed 24/07/16

Trade details

Type: Insider sale
Amount: $742,943.25
Shares · price: 16,455 sh · $45.15 a share
Held after: 95,740 sh
Stock: Kymera Therapeutics KYMR
Person: Jared GollobChief Medical Officer
Trade date: 24/07/15
Filed: 24/07/16
Days to filing: 1 days

Sold 14.7% of holdings

Share of holding sold: 14.7%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 24/06/15~24/08/14

Jared Gollob's recent trades

Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$273.3K
3,048 sh
$273.3K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$214.2K
2,519 sh
$214.2K
Filed 03/04
Traded 03/04
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$132.5K
1,510 sh
$132.5K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$123.3K
1,437 sh
$123.3K
Filed 03/04
Traded 03/04
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$93.4K
1,055 sh
$93.4K
Filed 03/04
Traded 03/02

Jared Gollob, Chief Officer — sold $742.9K of Kymera Therapeutics KYMR · 14.7% of holdings · 10b5-1 plan | Whalegun